ATE232113T1 - Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen - Google Patents

Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen

Info

Publication number
ATE232113T1
ATE232113T1 AT99944937T AT99944937T ATE232113T1 AT E232113 T1 ATE232113 T1 AT E232113T1 AT 99944937 T AT99944937 T AT 99944937T AT 99944937 T AT99944937 T AT 99944937T AT E232113 T1 ATE232113 T1 AT E232113T1
Authority
AT
Austria
Prior art keywords
throbosis
prophylaxis
artery
composition containing
coating agent
Prior art date
Application number
AT99944937T
Other languages
English (en)
Inventor
Erik Holmer
Original Assignee
Carmeda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmeda Ab filed Critical Carmeda Ab
Application granted granted Critical
Publication of ATE232113T1 publication Critical patent/ATE232113T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
AT99944937T 1998-09-09 1999-09-09 Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen ATE232113T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO984144A NO984144L (no) 1998-09-09 1998-09-09 Sammensetning som omfatter heparin som et ikke-trombogent overflatebelegg
PCT/NO1999/000278 WO2000013719A1 (en) 1998-09-09 1999-09-09 Composition comprising heparin as a non-thrombogenic surface coating agent

Publications (1)

Publication Number Publication Date
ATE232113T1 true ATE232113T1 (de) 2003-02-15

Family

ID=19902394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944937T ATE232113T1 (de) 1998-09-09 1999-09-09 Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen

Country Status (13)

Country Link
US (1) US6559132B1 (de)
EP (1) EP1112098B1 (de)
JP (1) JP4489297B2 (de)
KR (1) KR100603224B1 (de)
AT (1) ATE232113T1 (de)
AU (1) AU762201B2 (de)
BR (1) BR9913517A (de)
CA (1) CA2342992C (de)
DE (1) DE69905258T2 (de)
DK (1) DK1112098T3 (de)
ES (1) ES2192860T3 (de)
NO (1) NO984144L (de)
WO (1) WO2000013719A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
WO2000015147A1 (en) 1998-09-10 2000-03-23 Percardia, Inc. Transmycardial shunt and its attachment mechanism, for left ventricular revascularization
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
JP2003524444A (ja) * 1998-09-10 2003-08-19 パーカーディア，インコーポレイティド Ｔｍｒシャント
US6409697B2 (en) 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
US7033372B1 (en) 1999-08-04 2006-04-25 Percardia, Inc. Corkscrew reinforced left ventricle to coronary artery channel
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
JP3782297B2 (ja) * 2000-03-28 2006-06-07 株式会社東芝 固体撮像装置及びその製造方法
US6854467B2 (en) * 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20020032478A1 (en) * 2000-08-07 2002-03-14 Percardia, Inc. Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel
US6976990B2 (en) 2001-01-25 2005-12-20 Percardia, Inc. Intravascular ventriculocoronary bypass via a septal passageway
US6783525B2 (en) 2001-12-12 2004-08-31 Megadyne Medical Products, Inc. Application and utilization of a water-soluble polymer on a surface
US6949118B2 (en) 2002-01-16 2005-09-27 Percardia, Inc. Encased implant and methods
US7008397B2 (en) 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
US6685704B2 (en) 2002-02-26 2004-02-03 Megadyne Medical Products, Inc. Utilization of an active catalyst in a surface coating of an electrosurgical instrument
US6619357B1 (en) 2002-04-24 2003-09-16 The Goodyear Tire & Rubber Company Belt package for super single truck tires
US6951559B1 (en) 2002-06-21 2005-10-04 Megadyne Medical Products, Inc. Utilization of a hybrid material in a surface coating of an electrosurgical instrument
US7326219B2 (en) * 2002-09-09 2008-02-05 Wilk Patent Development Device for placing transmyocardial implant
US6702850B1 (en) 2002-09-30 2004-03-09 Mediplex Corporation Korea Multi-coated drug-eluting stent for antithrombosis and antirestenosis
FR2846520B1 (fr) * 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
US7201870B2 (en) * 2003-01-14 2007-04-10 Medtronic, Inc. Active air removal system operating modes of an extracorporeal blood circuit
US7198751B2 (en) * 2003-01-14 2007-04-03 Medtronic, Inc. Disposable, integrated, extracorporeal blood circuit
US7189352B2 (en) * 2003-01-14 2007-03-13 Medtronic, Inc. Extracorporeal blood circuit priming system and method
US7204958B2 (en) * 2003-01-14 2007-04-17 Medtronic, Inc. Extracorporeal blood circuit air removal system and method
US7335334B2 (en) * 2003-01-14 2008-02-26 Medtronic, Inc. Active air removal from an extracorporeal blood circuit
WO2005097223A1 (en) * 2004-03-26 2005-10-20 Surmodics, Inc. Composition and method for preparing biocompatible surfaces
EP1735024A1 (de) * 2004-03-26 2006-12-27 SurModics, Inc. Verfahren und systeme für biokompatible oberflächen
WO2005115490A2 (en) * 2004-05-25 2005-12-08 Surmodics, Inc. Natural biodegradable polysaccharide coatings for meical articles
US20060154894A1 (en) * 2004-09-15 2006-07-13 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8114465B2 (en) 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
US20090018646A1 (en) 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090036841A1 (en) * 2007-08-01 2009-02-05 Mckale James M Coatings for blood and bone marrow-contacting devices
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
EP2398524B1 (de) * 2009-02-21 2017-07-12 Covidien LP Medizinische vorrichtungen mit aktivierten oberflächen
CA2738676A1 (en) * 2009-02-21 2010-08-26 Sofradim Production Medical device with degradation-retarding coating
US20110196478A1 (en) * 2010-02-10 2011-08-11 Beoptima Inc. Devices and methods for lumen treatment
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US9180274B2 (en) 2010-09-09 2015-11-10 W. L. G ore & Associates, Inc Indwelling luminal devices
IT1402059B1 (it) * 2010-09-29 2013-08-28 Rand Srl Sistema indossabile per eseguire terapie depurative di fluidi organici con l'impiego di circuiti extracorporei
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
EP2985042B1 (de) 2013-04-12 2019-03-06 Toray Industries, Inc. Antithrombotisches künstliches blutgefäss
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2016150806A1 (en) 2015-03-20 2016-09-29 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
EP3288495B1 (de) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Vorrichtung mit reduzierter herzschrittmacherrate bei herzklappenersatz
EP3095509A1 (de) 2015-05-18 2016-11-23 Defymed Funktionalisierte membrane für biokünstliche organe
JP7081749B2 (ja) 2016-05-13 2022-06-07 イエナバルブ テクノロジー インク 心臓弁プロテーゼ送達システム
EP3318294A1 (de) 2016-11-08 2018-05-09 Defymed Kit zur in situ-ausgabe einer verbindung von interesse
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
KR20200037574A (ko) 2018-10-01 2020-04-09 (주)우리비앤비 헤파린을 포함하는 탈모방지용 화장료 조성물
EP4132462A1 (de) 2020-04-09 2023-02-15 Defymed Membranen für medizinische vorrichtungen
EP3892259A1 (de) 2020-04-09 2021-10-13 Defymed Membranen für medizinische vorrichtungen
JP2023537776A (ja) * 2020-08-14 2023-09-05 イドリス・オンコロジー・ベーフェー ヒアルロン酸を含むコーティングを医療用サンプリングデバイスの表面上に適用するための方法、及び循環腫瘍細胞を捕捉するための該コーティングを備えた医療用サンプリングデバイス
WO2024102411A1 (en) 2022-11-09 2024-05-16 Jenavalve Technology, Inc. Catheter system for sequential deployment of an expandable implant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446126A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production
SE456347B (sv) 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
US6174326B1 (en) 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
NO984144L (no) 2000-03-10
JP2002524153A (ja) 2002-08-06
EP1112098B1 (de) 2003-02-05
EP1112098A1 (de) 2001-07-04
US6559132B1 (en) 2003-05-06
KR20010079758A (ko) 2001-08-22
WO2000013719A1 (en) 2000-03-16
DE69905258D1 (de) 2003-03-13
KR100603224B1 (ko) 2006-07-24
ES2192860T3 (es) 2003-10-16
CA2342992A1 (en) 2000-03-16
AU762201B2 (en) 2003-06-19
BR9913517A (pt) 2001-06-05
JP4489297B2 (ja) 2010-06-23
DK1112098T3 (da) 2003-05-05
CA2342992C (en) 2010-11-23
NO984144D0 (no) 1998-09-09
AU5765399A (en) 2000-03-27
DE69905258T2 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
ATE232113T1 (de) Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen
ATE446776T1 (de) Zusammensetzung zur gefässbeschichtung
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE3775449D1 (de) Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung.
DE3854635D1 (de) Verwendung von hitzehärtbaren Organopolysiloxanzusammensetzungen als Beschichtungsmitteln oder Klebemitteln.
DE60142738D1 (de) Klarspülmittelzusammensetzung und verfahren zum klarspülen einer substratoberfläche
ATE326524T1 (de) Verwendung von lactobacillus zur verminderung des fibrinogengehalts im blut
ATE254953T1 (de) An der oberfläche modifizierte, biocompatible membranen
DE60015926D1 (de) Wasser-abfluss begrenzende reinigungsartikel
DE69426419D1 (de) Silylierte Polyamin-Polymere als Schmiermittel mit und ohne andere Komponenten, mit den Polymeren behandelte Substrate und Verfahren zur Behandlung der Substrate
EP0587101A3 (de) Vorrichtung zur Entfernung von Aluminiumionen aus Blut und Lösung zur Verwendung in der Vorrichtung.
BR0115579A (pt) Processo de limpeza de louça com a utilização de uma esponja
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
BR9708553A (pt) Processo para limpeza de um substrato e uso de umsistema ativador de oxigenio molecular
DE69109401D1 (de) Wässrige Zusammensetzungen zur Behandlung von porösen Substraten.
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
DE59106539D1 (de) Verfahren zur Oberflächenbehandlung von Bauteilen.
DE60017733D1 (de) Verwendung von riluzol zur behandlung multipler sklerose
DE59101843D1 (de) Vorrichtung zur laufenden Beschichtung von bandförmigen Substraten.
DE69832066D1 (de) Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
DE60106158D1 (de) Verfahren zur Herstellung von Organosilizium-Zusammensetzungen
ATE259408T1 (de) Reinigungsmittel
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112098

Country of ref document: EP